The move could save taxpayers between $113 and $165 million per year, regulators say
Karl Hille
Baltimore Sun
May 28, 2026
Excerpt:
Healthcare advocates called the action a win for both taxpayers and patients.
“We have seen the considerable impacts that the cost of Ozempic has had on patients, our health care system, and our state and local governments,” said Vincent DeMarco, head of the Maryland Health Care for All! Coalition advocacy group. “Many patients are finding that Ozempic is no longer covered by insurance, or that their premiums have gone up.”
Read the full article at BaltimoreSun.com.
Last modified: May 19, 2026
